Incidence of progressive multifocal leukoencephalopathy in patients without HIV
- 12 October 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 75 (15), 1326-1332
- https://doi.org/10.1212/wnl.0b013e3181f73600
Abstract
Objective: To estimate the incidence rate (IR) of progressive multifocal leukoencephalopathy (PML) in patients without HIV. Methods: Within a large US health insurer database between January 2000 and June 2008, we conducted a retrospective observational study. We identified people with autoimmune diseases, chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL), or history of bone marrow or solid organ transplantation, and a general population cohort. We developed a PML case-finding algorithm and validated PML diagnoses in medical charts. Results: There were 138,469 patients with autoimmune diseases, 25,706 with NHL or CLL, and 8,778 with transplants. Among 699 people who met screening criteria for potential PML, 89 had a claim diagnosis of PML (International Classification of Diseases–9 046.3). Medical records were sought for 24 patients without HIV, and 6 had confirmed PML upon review of medical records. The PML IR was 2.4 (95% confidence interval [CI] 0.06–13.18) in the systemic lupus erythematosus cohort and 10.8 (95% CI 0.27–60.39) in the autoimmune vasculitis cohort per 100,000 person-years. In the NHL and CLL cohorts, the IR was 8.3 (95% CI 1.71–24.24) and 11.1 (0.28–61.74) per 100,000 person-years. The IR among patients with bone marrow transplantation was 35.4 per 100,000 person-years (95% CI 0.90–197.29). There were no cases of PML among patients with rheumatoid arthritis (95% CI 0.0–2.24), multiple sclerosis (95% CI 0.0–5.24), Sjögren disease (95% CI 0.0–21.84), or solid organ transplantation (95% CI 0.0–26.81). Conclusions: In this large population-based investigation of PML with thorough case finding and a known source population, the IR of medical record–confirmed PML was rare in non-HIV patient cohorts.This publication has 18 references indexed in Scilit:
- Progressive Multifocal Leukoencephalopathy after Natalizumab MonotherapyThe New England Journal of Medicine, 2009
- Treatment of Progressive Multifocal Leukoencephalopathy Associated with NatalizumabThe New England Journal of Medicine, 2009
- Asymptomatic Reactivation of JC Virus in Patients Treated with NatalizumabThe New England Journal of Medicine, 2009
- Incidence and Outcome of Progressive Multifocal Leukoencephalopathy over 20 Years of the Swiss HIV Cohort StudyClinical Infectious Diseases, 2009
- Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk?Autoimmunity Reviews, 2008
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabThe New England Journal of Medicine, 2005
- Validity of Information on Comorbidity Derived From ICD-9-CCM Administrative DataMedical Care, 2002
- Sensitivity and positive predictive value of medicare part B physician claims for rheumatologic diagnoses and proceduresArthritis & Rheumatism, 1997
- Validity of rheumatoid arthritis diagnoses listed in the saskatchewan hospital separations databaseJournal of Clinical Epidemiology, 1993
- The accuracy of Medicare's hospital claims data: progress has been made, but problems remain.American Journal of Public Health, 1992